mdBriefCase Group Inc ( https://www.mdbriefcasegroup.com/) (the “Company” or “mdBriefCase”), the leading global online medical education provider serving general practitioners, specialists, pharmacists, nurses and other healthcare professionals in Australia, Canada, the Middle East, Africa, and around the world, is pleased to announce the appointment of Jason Flowerday as Chief Executive Officer (“CEO”).
As an executive and an entrepreneur, Flowerday brings more than two decades of industry experience focusing on operations management, business development, and strategy. “I’m extremely excited about the opportunity to lead the world-class team at mdBriefCase,” said Flowerday. “With a proven track record created over the past 17 years, and more than 170,000 members worldwide, mdBriefCase is in a great position to deliver new and exciting continuing medical education to improve patient care on a global scale.”
After the Company was founded in 2001, mdBriefCase Australia was established in 2006 to extend the delivery of interactive, peer-reviewed, evidence-based programs free of charge on its proprietary learning management system. With a membership of over 50,000 Australian healthcare professionals, mdBriefCase continues to innovate with new and engaging product offerings to a growing base of healthcare audiences. This year the Company has expanded its video offering to include interviews and cases presented by respected medical experts to address the growing popularity and consumption of relevant video content.
Key to mdBriefCase’s success are the strong partnerships it has with prestigious medical organisations and participation by key medical opinion leaders in Australia and around the world. “mdBriefCase is able to combine the best global education practices with leading Australian medical expertise to demonstrate the impact of its high-quality and engaging medical content,” says Suzanne Coutinho, Managing Director of mdBriefcase Australia. “We have expanded our educational library for Specialists, GPs, Pharmacists and Nurses in association with leading organisations in oncology, rheumatology, infectious diseases, and endocrinology to name just a few.”
Internationally, mdBriefCase has expanded to deliver learning content for healthcare professionals in 16 countries around the world. Alongside programs available in Europe and the United States, mdBriefCase offers programs to members in emerging markets such as Africa, the Middle East, Central and South America, and Asia.
“We are fully committed to supporting mdBriefCase as the Company continues its global expansion strategy,” added John Trang, Partner at Persistence Capital Partners (https://www.persistencecapital.com/) , private equity partners of mdBriefCase. “I’m excited about Jason’s addition to the organisation and what we will achieve together, in partnership with some of the most respected medical organisations in the world.”
Before joining mdBriefCase, Flowerday held CEO positions at 3D Signatures Inc., a publicly traded, personalised medical software company, Pro Bono Bio Inc., a biotechnology and medical device company based in the United Kingdom and Knight Therapeutics Inc. Previously, he spent over a decade at Bayer Healthcare and Ortho Biotech before co-founding and selling a pair of successful start-ups, which included a digital healthcare medical education company.
Flowerday’s academic credentials include a B.Sc. from the University of Toronto and an MBA from the Queen’s School of Business.
About mdBriefCase Group
mdBriefCase Group Inc. specialises in developing online, accredited continuing professional development for healthcare professionals. The company partners with prestigious regional and international medical associations to ensure its innovative education programs reflect the local experiences of healthcare professionals around the world. Its programs are peer-reviewed by clinical specialists to ensure balance and applicability to practice. Over 170,000 healthcare professionals have free access to the latest evidence-based information and guidelines to improve local patient care.